CBL mutations in pediatric solid and CNS tumors are a marker of receptor tyrosine kinase activation and a potential therapeutic target
Lauren M. Brown, Chelsea Mayoh, Katherine A Camper, Gábor Tax, Pablo Acera Mateos, Wenyan Li, Sam El-Kamand, Patricia A. Sullivan, James Bradley, Paris I. Thompson, Jingwei Chen, Teresa Sadras, Robert Salomon, Marie Wong, Mark J. Cowley, , Paul G. Ekert
bioRxiv · Dec 5, 2025 · PreprintCancer Biology